Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

833.56
+5.060.61%
Pre-market: 820.66-12.9025-1.55%04:01 EDT
Volume:505.42K
Turnover:421.46M
Market Cap:85.82B
PE:20.62
High:839.94
Open:829.22
Low:823.44
Close:828.50
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:0.70
T/O Rate:0.51%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.71
PE(LYR):20.10

Loading ...

Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 06, 2026

Major Issues Report

Form 8-K - Current report
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Apr 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Major Issues Report

Form 8-K - Current report
Apr 08, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities